Co-locating Convergent's manufacturing at NorthStar establishes an integrated and reliable supply chain for CONV01-<ALPHA> drug product production with Ac-225, relieving supply constraints for ...
Convergent Energy and Power Closes $584.5 Million Guaranteed Loan from the U.S. Department of Energy
NEW YORK--(BUSINESS WIRE)--Convergent Energy and Power (Convergent), a leading provider of energy storage solutions in North America, today announced the closing of its $584.5 million guaranteed loan ...
Convergent hybrid ablation is an innovative treatment for a type of irregular heart rhythm called atrial fibrillation (AFib). The treatment is a two-stage procedure that combines the expertise of our ...
NEW YORK--(BUSINESS WIRE)--Convergent Energy and Power (Convergent), a leading provider of energy storage solutions in North America, today announced the publication of its 2022 Sustainability and ...
Purpose-built facility secures Convergent’s drug product manufacturing at the scale needed to meet late-stage CONV01-α clinical studies and commercial demand Expanded partnership designed to drive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback